JCOIN Research
Testing Implementation Strategies to Scale Up a Multicomponent Continuum of Service Intervention for Families Involved in Systems with Parental Opioid and Methamphetamine Use
Just Care for Families (JCFF) is an emerging practice for parents and their children, developed to address their interrelated substance use, mental health, relational, community-building, systems-navigating, and basic-treatment needs. This study examines clinical outcomes at interception points between the JCFF and child welfare (CW) systems and implementation outcomes when JCFF is delivered with the addition…
Read MoreThe RELIEF Study: Court Fees as a Determinant of Health and Criminal-legal Outcomes
This study aims to understand how financial pressures related to criminal justice involvement contribute to issues like food and housing insecurity, repeat offenses, and overdose deaths. The study addresses the effects of a new law in New Mexico (House Bill 139) that eliminated court fees starting in 2024. By treating this policy change as a…
Read MoreEvaluating a Novel Approach to Dispensing Methadone in Carceral Facilities
Methadone has been hard to access in prisons and jails due to federal rules limiting its use to specific treatment programs. A new rule from the Substance Abuse and Mental Health Services Administration (SAMHSA) specifies that carceral facilities registered as “hospital/clinic” facilities can stock and dispense methadone, provided patients have another health condition in addition…
Read MoreStrengthening Buprenorphine Treatment for Individuals in Carceral Settings (STAND): A Hybrid Implementation-Effectiveness Trial of Long-Acting Injectable Versus Sublingual Buprenorphine
This study is a large hybrid type 1 effectiveness-implementation randomized controlled trial evaluating the comparative effectiveness of long-acting injectable buprenorphine (XRB) versus sublingual buprenorphine (SLB) among incarcerated adult volunteers with opioid use disorder (OUD) who are preparing for release. The study addresses the urgent need for high-quality data comparing these two buprenorphine formulations in corrections-to-community…
Read MoreImproving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes
Despite jails being required to provide medical care, only around 20% offer medications to treat opioid addiction, and even fewer provide easy access to these treatments. Rural jails, which make up two-thirds of all jails, face big challenges in offering these programs due to operational and logistical difficulties, resulting in inconsistent access to proper care.…
Read MorePolice Pathways to Addiction Treatment, Health, and Safety: The Police PATHS Study
Police interactions with people who use drugs (PWUD) can lead to arrests for minor offenses, which can increase the risk of overdose and result in other adverse health outcomes for individuals. Police-assisted diversion (PAD) offers an alternative to arrest by connecting people to treatment and services, including medication for opioid use disorder. PAD aims to…
Read MoreRecovery Management Checkup Scalability and Sustainability (RMC-SS) Hybrid Experiment: Evaluating Comparability of Client and Implementation Outcomes in Community Organizations Post-Arrest
Recovery Management Checkup (RMC) uses a structured, motivational-interviewing based protocol delivered by linkage managers through regular check-ups. Chestnut Health Systems is conducting a hybrid type 2 effectiveness-implementation trial guided by the Exploration, Preparation, Implementation, and Sustainability (EPIS) framework which: 1) integrates RMC into community-based programs in four discrete areas in Chicago with the highest risk…
Read MoreA patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail
This study tests two forms of buprenorphine treatment, extended-release buprenorphine (XR-B) and sublingual buprenorphine (SL-B) for adults with opioid use disorder (OUD) who are returning to the community from jail. The study treatment will be delivered via telemedicine both in jail and in the community. The treatment starts in jail and continues for six months…
Read MoreMassachusetts Justice Community Overdose Innovation Network (Mass JCOIN) Phase 2
The federal Medicaid Inmate Exclusion Policy (MIEP), which removes Medicaid eligibility during incarceration, is an obstacle to transitional treatment during community reentry. However, Massachusetts has received federal approval for a MIEP waiver to restart MassHealth (i.e., Medicaid) coverage 90 days before release to the community in four pilot jails that deliver MOUD and have participated…
Read More